Comments
Loading...
Co-Diagnostics (NASDAQ:CODX) Stock, Guidance And Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Data brought to you by Benzinga APIs
FAQ
What is the most recent guidance for Co-Diagnostics (CODX)?
The most recent guidance for Co-Diagnostics (CODX) was reported on March 24, 2022 for Q1 2022. The company provided earnings per share guidance in the range of $0.17 to $0.20, compared to the estimated EPS of $0.11. Additionally, Co-Diagnostics forecasted revenue between $0.02B and $0.02B for the quarter.
Browse guidance and forecast on all stocks.